Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graybill

Showing results (261-270 of 539) with videos related to

Pageof 54
Sort By:
The Journal of Infectious Diseases|August 1, 1993
Correlation of in vitro azole susceptibility with in vivo response in a murine model of cryptococcal meningitisJ D Velez, R Allendoerfer, M Luther, et al.
The Journal of Antimicrobial Chemotherapy|November 18, 1998
SCH56592 treatment of murine invasive aspergillosisJ R Graybill, R Bocanegra, L K Najvar, et al.
Journal of Clinical & Cellular Immunology|November 25, 2014
Increased Education is Associated with Decreased Compliance in an Urban Multi-Ethnic Lupus CohortRachel Gross, Jennifer Graybill, Dawn Wahezi, et al.
Biomicrofluidics|March 25, 2021
A constriction channel analysis of astrocytoma stiffness and disease progressionP M Graybill, R K Bollineni, Z Sheng, et al.
Antimicrobial Agents and Chemotherapy|November 24, 2005
Caspofungin and liposomal amphotericin B therapy of experimental murine scedosporiosisRosie Bocanegra, Laura K Najvar, Steve Hernandez, et al.
The Journal of Infectious Diseases|May 1, 1993
Induction of tumor necrosis factor-alpha in murine Candida albicans infectionR Allendoerfer, D M Magee, J G Smith, et al.
Patient Education and Counseling|March 12, 2018
Who's distressed? A comparison of diabetes-related distress by type of diabetes and medicationJana L Wardian, Joshua Tate, Irene Folaron, et al.
Mycopathologia|April 23, 1982
Immunogenic fractions of Cryptococcus neoformansJ R Graybill, D C Straus, T J Nealon, et al.
Antimicrobial Agents and Chemotherapy|July 2, 1999
Activities of sordarins in murine histoplasmosisJ R Graybill, L Najvar, A Fothergill, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1995
Fluconazole treatment of Candida albicans infection in mice: does in vitro susceptibility predict in vivo response?J R Graybill, L K Najvar, J D Holmberg, et al.
Pageof 54

Showing results (261-270 of 539) with videos related to

Sort By:
Pageof 54
The Journal of Infectious Diseases|August 1, 1993
Correlation of in vitro azole susceptibility with in vivo response in a murine model of cryptococcal meningitisJ D Velez, R Allendoerfer, M Luther, et al.
The Journal of Antimicrobial Chemotherapy|November 18, 1998
SCH56592 treatment of murine invasive aspergillosisJ R Graybill, R Bocanegra, L K Najvar, et al.
Journal of Clinical & Cellular Immunology|November 25, 2014
Increased Education is Associated with Decreased Compliance in an Urban Multi-Ethnic Lupus CohortRachel Gross, Jennifer Graybill, Dawn Wahezi, et al.
Biomicrofluidics|March 25, 2021
A constriction channel analysis of astrocytoma stiffness and disease progressionP M Graybill, R K Bollineni, Z Sheng, et al.
Antimicrobial Agents and Chemotherapy|November 24, 2005
Caspofungin and liposomal amphotericin B therapy of experimental murine scedosporiosisRosie Bocanegra, Laura K Najvar, Steve Hernandez, et al.
The Journal of Infectious Diseases|May 1, 1993
Induction of tumor necrosis factor-alpha in murine Candida albicans infectionR Allendoerfer, D M Magee, J G Smith, et al.
Patient Education and Counseling|March 12, 2018
Who's distressed? A comparison of diabetes-related distress by type of diabetes and medicationJana L Wardian, Joshua Tate, Irene Folaron, et al.
Mycopathologia|April 23, 1982
Immunogenic fractions of Cryptococcus neoformansJ R Graybill, D C Straus, T J Nealon, et al.
Antimicrobial Agents and Chemotherapy|July 2, 1999
Activities of sordarins in murine histoplasmosisJ R Graybill, L Najvar, A Fothergill, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1995
Fluconazole treatment of Candida albicans infection in mice: does in vitro susceptibility predict in vivo response?J R Graybill, L K Najvar, J D Holmberg, et al.
Pageof 54